In the Flinders University study, of the 6954 women first prescribed GLP-1 receptor agonists during 2022, 90.5% did not have type 2 diabetes, suggesting that many were using the medication for weight loss
The placebo group (who received the same lifestyle advice but no medication) lost only about 2.4% of their weight To put this in context, semaglutide produces about twice the weight loss of older weight-loss medications
See also the semaglutide vs tirzepatide comparison for a broader overview of efficacy, side effects, and cost
For a comprehensive list of errors that extends beyond reconstitution to all aspects of peptide handling, the common peptide mistakes beginners make article covers over a dozen pitfalls that catch even experienced researchers off guard
If you have medical questions or known nutrient deficiencies, consult a healthcare provider for individualized guidance